ConMed CNMD
$46.56 +$0.18 (+0.39%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $46.56 0.00%
Open$46.11
Prev close$46.38
Day range$45.94 – $48.00
Volume384.3K
Market cap$1.39B
P/E (TTM)19.3
Dividend yield–
CNMD Stock News
Headlines matching ConMed or the CNMD ticker, most recent first.
- A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $45 to $46
- J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $40
- Needham Maintains ConMed(CNMD.US) With Hold Rating
- BofA Securities Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40 Negative
- Needham Maintains ConMed(CNMD.US) With Hold Rating, Announces Target Price $35.96
- J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $40 Negative
- Piper Sandler Maintains ConMed(CNMD.US) With Hold Rating, Maintains Target Price $39
- Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE)
- Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Cuts Target Price to $42 Negative
- Piper Sandler Downgrades ConMed(CNMD.US) to Hold Rating, Cuts Target Price to $39 Negative
- Wells Fargo Maintains ConMed(CNMD.US) With Hold Rating, Raises Target Price to $49 Positive
- Needham Maintains ConMed(CNMD.US) With Hold Rating
- J.P. Morgan Maintains ConMed(CNMD.US) With Hold Rating, Raises Target Price to $50 Positive
- Piper Sandler Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $55
- TR | OpenAI - 4o Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $60
No comments yet — be the first to weigh in on CNMD.
Sign in to join the discussion.